Literature DB >> 15549997

Use of dornase alfa in the management of ARDS.

C Morris, B Mullan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15549997     DOI： 10.1111/j.1365-2044.2004.04018.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN： 0003-2409            Impact factor:   6.955


× No keyword cloud information.
  6 in total

1.  Casting a wide NET: an update on uncontrolled NETosis in response to COVID-19 infection.

Authors:  Erin B Taylor
Journal:  Clin Sci (Lond)       Date:  2022-07-15       Impact factor: 6.876

Review 2.  Clinical review: airway hygiene in the intensive care unit.

Authors:  Sanja Jelic; Jennifer A Cunningham; Phillip Factor
Journal:  Crit Care       Date:  2008-03-31       Impact factor: 9.097

3.  Consideration of dornase alfa for the treatment of severe COVID-19 acute respiratory distress syndrome.

Authors:  A P Earhart; Z M Holliday; H V Hofmann; A G Schrum
Journal:  New Microbes New Infect       Date:  2020-04-30

4.  The Use of Dornase Alfa in the Management of COVID-19-Associated Adult Respiratory Distress Syndrome.

Authors:  Andrew Toma; Christina Darwish; Michele Taylor; Justin Harlacher; Ribal Darwish
Journal:  Crit Care Res Pract       Date:  2021-04-23

5.  Nebulized in-line endotracheal dornase alfa and albuterol administered to mechanically ventilated COVID-19 patients: A case series.

Authors:  Andrew G Weber; Alice S Chau; Mikala Egeblad; Betsy J Barnes; Tobias Janowitz
Journal:  medRxiv       Date:  2020-05-15

6.  Nebulized in-line endotracheal dornase alfa and albuterol administered to mechanically ventilated COVID-19 patients: a case series.

Authors:  Andrew G Weber; Alice S Chau; Mikala Egeblad; Betsy J Barnes; Tobias Janowitz
Journal:  Mol Med       Date:  2020-09-29       Impact factor: 6.354
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.